The big memo is in the headlines again this week with the announcement that the HHS will be releasing an un-redacted version of the memo an attorney pursued litigation to force the agency to produce the document. A highly redacted version was released last year which amounted to almost no information for the public. This followed a FOIA request that missed the deadline to produce the documents and was the basis for the lawsuit. The DEA has recently responded to the recommendation by claiming they are now conducting their own review of the schedule status of cannabis as a schedule I substance. Their review should be scientifically based on available medical data and public policy. This could potentially lead to a major shift in the cannabis industry as it would open up more opportunities for research, production, and distribution. The cannabis industry has been rapidly growing in recent years, with more and more states legalizing its use for both medical and recreational purposes. This memo could be the impetus for actual policy changes that lead to legalization at the federal level. One of the biggest obstacles facing the cannabis industry is its federal classification as a schedule I substance, meaning it is considered to have no medical value and a high potential for abuse. This has limited research on the plant and hindered efforts to fully legalize it at the federal level. However, if cannabis were to be reclassified as a schedule III substance, it would join other drugs such as codeine and ketamine which are deemed to have some medical benefits. Tune in to Cannabis Legalization News with Tom Howard and Miggy 420 to see more about this story and other of the week's top events in the cannabis legalization. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabisindustry #cannabislegalization #CannabisCommunity #420 #CannabisCulture #Weed #CannabisLovers #CannabisDaily #CannabisLife #StayHigh #Budtenders #MedicalMarijuana #Hemp #Dab #Weedstagram #HighTimes #WeedLovers #Sativa #Indica #CBD #THC #CannabisIndustry 🍁🌱🔥🌬️🍃🌳🌞🚬
The big memo is in the headlines again this week with the announcement that the HHS will be releasing an un-redacted version of the memo an attorney pursued litigation to force the agency to produce the document. A highly redacted version was released last year which amounted to almost no information for the public. This followed a FOIA request that missed the deadline to produce the documents and was the basis for the lawsuit. The DEA has recently responded to the recommendation by claiming they are now conducting their own review of the schedule status of cannabis as a schedule I substance. Their review should be scientifically based on available medical data and public policy. This could potentially lead to a major shift in the cannabis industry as it would open up more opportunities for research, production, and distribution. The cannabis industry has been rapidly growing in recent years, with more and more states legalizing its use for both medical and recreational purposes. This memo could be the impetus for actual policy changes that lead to legalization at the federal level. One of the biggest obstacles facing the cannabis industry is its federal classification as a schedule I substance, meaning it is considered to have no medical value and a high potential for abuse. This has limited research on the plant and hindered efforts to fully legalize it at the federal level. However, if cannabis were to be reclassified as a schedule III substance, it would join other drugs such as codeine and ketamine which are deemed to have some medical benefits. Tune in to Cannabis Legalization News with Tom Howard and Miggy 420 to see more about this story and other of the week's top events in the cannabis legalization. Get in touch with us: 🌱 We can help with your cannabis business. Here is our info. (https://bit.ly/m/collateral-base) 🔔 Subscribe to CLN for more cannabis content! (https://bit.ly/2VJUAQr) 💚 Become a member for exclusive perks! (https://bit.ly/2UavaLj 📚 Learn more about the 🥦 Industry! (http://bit.ly/3Jo4VIz) #cannabisreform #cannabisindustry #cannabislegalization #CannabisCommunity #420 #CannabisCulture #Weed #CannabisLovers #CannabisDaily #CannabisLife #StayHigh #Budtenders #MedicalMarijuana #Hemp #Dab #Weedstagram #HighTimes #WeedLovers #Sativa #Indica #CBD #THC #CannabisIndustry 🍁🌱🔥🌬️🍃🌳🌞🚬